Complex genetic background in a large family with Brugada syndrome
Author(s) -
Saber Siamak,
Amarouch MohamedYassine,
Fazelifar AmirFarjam,
Haghjoo Majid,
Emkanjoo Zahra,
Alizadeh Abolfath,
Houshmand Massoud,
Gavrilenko Alexander V.,
Abriel Hugues,
Zaklyazminskaya Elena V.
Publication year - 2015
Publication title -
physiological reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 39
ISSN - 2051-817X
DOI - 10.14814/phy2.12256
Subject(s) - brugada syndrome , sodium channel , nav1.5 , mutation , medicine , mutant , gene , genetics , sudden cardiac death , biology , chemistry , organic chemistry , sodium
The Brugada syndrome (BrS) is an inherited arrhythmia characterized by ST ‐segment elevation in V 1 –V 3 leads and negative T wave on standard ECG . BrS patients are at risk of sudden cardiac death ( SCD ) due to ventricular tachyarrhythmia. At least 17 genes have been proposed to be linked to BrS, although recent findings suggested a polygenic background. Mutations in SCN 5A , the gene coding for the cardiac sodium channel Na v 1.5, have been found in 15–30% of index cases. Here, we present the results of clinical, genetic, and expression studies of a large Iranian family with BrS carrying a novel genetic variant (p.P1506S) in SCN 5A . By performing whole‐cell patch‐clamp experiments using HEK 293 cells expressing wild‐type ( WT ) or p.P1506S Na v 1.5 channels, hyperpolarizing shift of the availability curve, depolarizing shift of the activation curve, and hastening of the fast inactivation process were observed. These mutant‐induced alterations lead to a loss of function of Na v 1.5 and thus suggest that the p.P1506S variant is pathogenic. In addition, cascade familial screening found a family member with BrS who did not carry the p.P1506S mutation. Additional next generation sequencing analyses revealed the p.R25W mutation in KCNH 2 gene in SCN 5A ‐negative BrS patients. These findings illustrate the complex genetic background of BrS found in this family and the possible pathogenic role of a new SCN 5A genetic variant.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom